PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50125C00008OSIVAX - clinical PROOF of concept — Osivax

Osivax holds $20.2M across 2 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jul 24, 2028 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Osivax

Recipient

Jul 24, 2028

PoP end

$19.5M

Obligated

$98.6M

Potential

541714

NAICS

AN11

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Osivax — $90

Contract facts

NONE

Contract number75A50125C00008

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentOsivax

CAGEFBDR2

UEIM4YDKJJRJYC7

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN11

Pricing typeCost Sharing

Extent competedFull And Open Competition

PoP startJul 25, 2025

PoP end (current)Jul 24, 2028

Obligated$19.5M

Current value$19.5M

Potential value$98.6M

OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST EMERGING PANDEMIC STRAINS is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Osivax. Estimated value $98.6M ($19.5M obligated). Current period of performance ends Jul 24, 2028. Last award drew 1 bidder.

OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST EMERGING PANDEMIC STRAINS

Recompete timing

Public

● Expiring in 686 days

Current PoP ends Jul 24, 2028 (686 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jan 24, 2027.

Incumbent footprint

Public record

Osivax — $20.2M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$20.2M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

75A50125C00006

OXIVAX - AOI #28: INFLUENZA VACCINE INNOVATION. ADVANCING METAGENOMIC NEXT-GENERATION SEQU…

$744K

Mar 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50125C00008?

75A50125C00008 (OSIVAX - clinical PROOF of concept) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $98.6M, currently held by Osivax. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50125C00008?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50125C00008 to Osivax (potential $98.6M).

Who is the incumbent on 75A50125C00008?

Osivax is the incumbent with $20.2M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Jul 24, 2028.

When does Osivax’s 75A50125C00008 come up for recompete?

SCOUT tracks a period-of-performance end of Jul 24, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50125C00008 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action May 19, 2026